KWELLS hyoscine hydrobromide 0.3mg chewable tablet blister pack (new formulation)

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

hyoscine hydrobromide, Quantity: 300 microgram

Disponible depuis:

iNova Pharmaceuticals (Australia) Pty Ltd

DCI (Dénomination commune internationale):

Hyoscine hydrobromide

forme pharmaceutique:

Tablet, chewable

Composition:

Excipient Ingredients: saccharin sodium; iron oxide red; aluminium stearate; Gelatin; mannitol; potato starch

Mode d'administration:

Oral

Unités en paquet:

12

Type d'ordonnance:

(S2) Pharmacy Medicine

indications thérapeutiques:

For the prevention of travel sickness

Descriptif du produit:

Visual Identification: Small pink circular flat faced tablet with bevelled edges and a single break bar on one side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-07-16